News
A woman who had a spinal cord stimulator implanted in 2020 is suing devicemaker Boston Scientific and the FDA over complications she experienced with the device. Dena Lawler received the Spectra ...
BioMADE has bought a Maple Grove site for $16.5M to build a $132M biomanufacturing facility backed by the DoD and Minnesota ...
Nonprofit manufacturer BioMADE says the plant will enable other businesses to test and develop novel technologies derived ...
BioMADE, a collaboration of public and private enterprise pursuing the manufacturing of "high-value" chemicals, materials, ...
BioMADE, a biomanufacturing nonprofit backed by the U.S. Department of Defense, will establish a $132 million flagship location at a site in Maple Grove.
A $132 million manufacturing campus — where companies will transform crops into industrial chemicals otherwise made with petroleum and often sourced from overseas — is coming to Maple Grove. The ...
A pair of area natives turned in impressive times at the 129th running of the Boston Marathon on Monday. Jesse Rappole, the ...
Boston Scientific is doing what most other companies are not: increasing sales guidance for investors despite increasingly ...
BOSTON SCIENTIFIC ($BSX) is expected to release its quarterly earnings data on Wednesday, April 23rd before market open, per Finnhub. Analysts are expecting revenue ...
Monroe County Commissioners voted 2-to-1 last Thursday to downzone over 200 properties in the Sunset Hill and Maple Grove Baby Farms neighborhoods. The properties were originally zoned High ...
Boston Scientific (BSX) closed the most recent trading day at $95.12, moving -0.14% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.13%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results